Onset usually clusters in the first one to four weeks of treatment or around an increase in dose, and most cases resolve within two to six weeks as the body settles into a new metabolic steady state
c) the neurohormonal activation and chronic sympathetic hyperactivity further perturb GH secretion patterns and IGF-1 production [9396]
When to Discuss Cold Sensitivity With Your PlexusDx Provider If cold sensitivity is severe enough to interfere with your daily life, sleep, or ability to stick with treatment, contact your PlexusDx care team
The medication is intended for long-term use as part of chronic weight management, similar to treatment of other chronic conditions
Portillo Canales S et al
Regulatory guidelines from the Medicines and Healthcare products Regulatory Agency state that only people classified as clinically obese, with a Body Mass Index (BMI) of more than 30, or those who are overweight (BMI of 27-30) with at least one weight-related health condition such as high blood pressure or type 2 diabetes, will be eligible to receive the drug